University of Nebraska Medical Center

UNMC is a leading institution for health professionals and scientific research. They cover topics such as new COVID variants, vaccine development, and medical breakthroughs. The site provides accurate and up-to-date information with a high readability score.

72%

The overall score is a weighted number that takes into account conflict of interest, bias, deception and other practices that undermines the credibility of the source. It is calculated as:
Analysis.OverallConflictOfInterestScore * 0.3F + Analysis.OverallBiasScore * 0.3F + Analysis.DeceptivenessScore * 0.3F + Analysis.ReadabilityScore * 0.1F

A score that takes into consideration the content for flow, interruptions with ads, and overt search engine optimization techniques that makes the content hard to understand

The Daily's Verdict

This news site has a mixed reputation for journalistic standards. It is advisable to fact-check, scrutinize for bias, and check for conflicts of interest before relying on its reporting.

Bias

90%

Examples:

  • The bias found in the article is that JN.1 caused nearly half of new U.S. coronavirus infections in the two weeks leading up to Christmas, the Centers for Disease Control and Prevention estimates.

Conflicts of Interest

80%

Examples:

No current examples available.

Contradictions

95%

Examples:

No current examples available.

Deceptions

40%

Examples:

  • The deception found in the article is that it doesn't provide any direct information about Washington Post.

Recent Articles

  • New COVID-19 Subvariants KP.3, KP.2, and LB.1: Evading the Immune System and Surge in Cases During Summer Months

    New COVID-19 Subvariants KP.3, KP.2, and LB.1: Evading the Immune System and Surge in Cases During Summer Months

    Broke On: Wednesday, 26 June 2024 New COVID-19 subvariants KP.3, KP.2, and LB.1 are on the rise during summer months, causing an increase in cases due to their ability to evade the immune system effectively. Vulnerable populations are at higher risk for severe disease but vaccination remains the best defense against infection and severe illness as new vaccine formulations targeting these subvariants become available this fall.
  • New mRNA Vaccine Effectively Prevents H5N1 Avian Flu in Lab Animals: Rapid Production Key to Pandemic Preparedness

    New mRNA Vaccine Effectively Prevents H5N1 Avian Flu in Lab Animals: Rapid Production Key to Pandemic Preparedness

    Broke On: Tuesday, 28 May 2024 Scientists have developed an mRNA vaccine for the H5N1 avian flu using COVID vaccine techniques, allowing for rapid production and effective prevention of severe illness and death in lab animals. The H5N1 virus is spreading among wild birds, poultry, and cows in the US, posing a threat to human populations. The US Department of Health and Human Services plans to produce 4.8 million doses for pandemic preparedness.
  • JN.1: The Latest COVID-19 Variant to Gain Attention in the US

    JN.1: The Latest COVID-19 Variant to Gain Attention in the US

    Broke On: Friday, 05 January 2024 JN.1, a new variant of COVID-19 that makes up an estimated 40% to 50% of circulating variants in the US as of December 23rd, is gaining attention due to its ability to infect vaccinated or previously infected individuals more easily than some other strains. Despite this, there is currently no evidence that JN.1 causes different symptoms from other variants and existing vaccines still work well against it. It's important for individuals and healthcare systems to stay vigilant and continue following public health guidelines.